Bank Julius Baer & Co
MRVI icon

Bank Julius Baer & Co’s Maravai LifeSciences MRVI Stock Holding History

Bank Julius Baer & Co’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-810
Closed -$1.95K – 690
2025
Q2 		$1.95K Sell
810
-34
-4% -$71 ﹤0.01% 599
2025
Q1 		$1.86K Buy
844
+120
+17% +$474 ﹤0.01% 600
2024
Q4 		$4.35K Buy
724
+49
+7% +$315 ﹤0.01% 613
2024
Q3 		$6.65K Sell
675
-27
-4% -$233 ﹤0.01% 500
2024
Q2 		$5.59K Sell
702
-88
-11% -$760 ﹤0.01% 481
2024
Q1 		$6.85K Sell
790
-21
-3% -$142 ﹤0.01% 517
2023
Q4 		$5.31K Sell
811
-208,838
-100% -$1.35M ﹤0.01% 533
2023
Q3 		$2.1M Sell
209,649
-3,971
-2% -$43.6K 0.01% 205
2023
Q2 		$2.65M Sell
213,620
-5,560
-3% -$75K 0.02% 197
2023
Q1 		$3.07M Sell
219,180
-3,122
-1% -$44.8K 0.02% 193
2022
Q4 		$3.18M Buy
222,302
+7,518
+4% +$118K 0.02% 195
2022
Q3 		$5.48M Buy
214,784
+1,138
+0.5% +$28.6K 0.04% 160
2022
Q2 		$6.07M Buy
213,646
+69,570
+48% +$2.2M 0.04% 165
2022
Q1 		$5.08M Sell
144,076
-7,148
-5% -$240K 0.03% 174
2021
Q4 		$6.34M Buy
151,224
+18,572
+14% +$752K 0.03% 185
2021
Q3 		$6.51M Buy
132,652
+48,923
+58% +$2.39M 0.04% 185
2021
Q2 		$3.49M Buy
+83,729
New +$3.25M 0.02% 233

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Bank Julius Baer & Co's MRVI Position: Q3 2025 in Review

Bank Julius Baer & Co sold out of Maravai LifeSciences (MRVI) in Q3 2025, closing a stake of 810 shares — an estimated $1.95K sold.

Bank Julius Baer & Co first reported a position in MRVI in Q2 2021 and held it in 17 quarters. The position peaked at $6.51M in Q3 2021. 160 funds tracked by Wall St. Rank hold MRVI as of Q3 2025.

  • Bank Julius Baer & Co reported no remaining Maravai LifeSciences position as of Q3 2025 after selling out during the quarter.
  • Bank Julius Baer & Co sold 810 Maravai LifeSciences shares in Q3 2025, an estimated $1.95K.
  • Bank Julius Baer & Co first reported a position in Maravai LifeSciences in Q2 2021 and held it in 17 quarters.
  • Bank Julius Baer & Co's Maravai LifeSciences position peaked at $6.51M in Q3 2021.
  • 160 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2025.

Based on Bank Julius Baer & Co's 13F filing for Q3 2025, filed 13 Nov 2025.